About Us | Contact

Pat F Bass Investigator

Ochsner Lsu Health Shreveport NPI1952321820
Update NPI

Open Payments

Note

The following payment details are based on a national transparency program known as the Sunshine Act that collects and publishes information about financial relationships between the health care industry (i.e. drug and device manufactures) and providers. These relationships may involve payment to providers for things such as research, speaking engagment, travel, gifts etc. Not all of these payment involve monetary compensations and may include batering of drugs or devices.

Total Payment Worth

$1,481.08
from 22 payments in the last 6 years

Total Cash or Cash Equivalent

$1,290.65
from 10 payments in the last 6 years

Total In-kind Items & Services

$190.43
from 12 payments in the last 6 years

Nature of Payments

Last 6 Years
Chart will render here...

Yearly Breakdown

Chart will render here...

Payment Details

Date Payment Type Form of Payment Item/Service Payment Amount
07/28/2020 General (Non-Research) In-kind items and services Food and Beverage $12.84 Details
Payment from PFIZER INC.
Payment Record ID 743264795
11/11/2020 General (Non-Research) In-kind items and services Food and Beverage $18.33 Details
Payment from Janssen Pharmaceuticals, Inc
Payment Record ID 719343649
03/12/2020 General (Non-Research) In-kind items and services Food and Beverage $14.86 Details
Payment from Janssen Pharmaceuticals, Inc
Payment Record ID 719343647
03/04/2020 General (Non-Research) In-kind items and services Food and Beverage $15.14 Details
Payment from Janssen Pharmaceuticals, Inc
Payment Record ID 719343645
08/10/2019 General (Non-Research) In-kind items and services Food and Beverage $12.85 Details
Payment from Janssen Pharmaceuticals, Inc
Payment Record ID 658303057
10/10/2018 General (Non-Research) In-kind items and services Food and Beverage $19.77 Details
Payment from PFIZER INC.
Payment Record ID 610326071
01/03/2017 Research Cash or cash equivalent $6.30 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study A Phase II, global, randomized study to evaluate the efficacy and safety of Danirixin GSK1325756 co administered with a standard of care antiviral oseltamivir , in the treatment of adults hospitalized with influenza
Payment Record ID 478886449
01/03/2017 Research Cash or cash equivalent $22.80 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study A Phase II, global, randomized study to evaluate the efficacy and safety of Danirixin GSK1325756 co administered with a standard of care antiviral oseltamivir , in the treatment of adults hospitalized with influenza
Payment Record ID 478886445
01/03/2017 Research Cash or cash equivalent $24.89 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study A Phase II, global, randomized study to evaluate the efficacy and safety of Danirixin GSK1325756 co administered with a standard of care antiviral oseltamivir , in the treatment of adults hospitalized with influenza
Payment Record ID 478886443
01/03/2017 Research Cash or cash equivalent $24.50 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study A Phase II, global, randomized study to evaluate the efficacy and safety of Danirixin GSK1325756 co administered with a standard of care antiviral oseltamivir , in the treatment of adults hospitalized with influenza
Payment Record ID 478886438
01/03/2017 Research Cash or cash equivalent $77.85 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study A Phase II, global, randomized study to evaluate the efficacy and safety of Danirixin GSK1325756 co administered with a standard of care antiviral oseltamivir , in the treatment of adults hospitalized with influenza
Payment Record ID 478886435
01/03/2017 Research Cash or cash equivalent $72.70 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study A Phase II, global, randomized study to evaluate the efficacy and safety of Danirixin GSK1325756 co administered with a standard of care antiviral oseltamivir , in the treatment of adults hospitalized with influenza
Payment Record ID 478886432
02/22/2017 Research Cash or cash equivalent $738.20 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study A Phase II, global, randomized study to evaluate the efficacy and safety of Danirixin GSK1325756 co administered with a standard of care antiviral oseltamivir , in the treatment of adults hospitalized with influenza
Payment Record ID 478886428
01/03/2017 Research Cash or cash equivalent $90.48 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study A Phase II, global, randomized study to evaluate the efficacy and safety of Danirixin GSK1325756 co administered with a standard of care antiviral oseltamivir , in the treatment of adults hospitalized with influenza
Payment Record ID 478886425
01/03/2017 Research Cash or cash equivalent $218.30 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study A Phase II, global, randomized study to evaluate the efficacy and safety of Danirixin GSK1325756 co administered with a standard of care antiviral oseltamivir , in the treatment of adults hospitalized with influenza
Payment Record ID 478886423
06/01/2017 General (Non-Research) In-kind items and services Food and Beverage $11.29 Details
Payment from BOSTON SCIENTIFIC CORPORATION
Payment Record ID 455582295
10/11/2016 General (Non-Research) Cash or cash equivalent Food and Beverage $14.63 Details
Payment from Arbor Pharmaceuticals, Inc.
Payment Record ID 420004883
06/29/2016 General (Non-Research) In-kind items and services Food and Beverage $19.89 Details
Payment from Endo Pharmaceuticals Inc.
Payment Record ID 405557374
05/16/2016 General (Non-Research) In-kind items and services Food and Beverage $10.38 Details
Payment from SANOFI PASTEUR INC.
Payment Record ID 389351808
02/29/2016 General (Non-Research) In-kind items and services Food and Beverage $18.72 Details
Payment from GlaxoSmithKline, LLC.
Payment Record ID 387713433
10/25/2016 General (Non-Research) In-kind items and services Food and Beverage $23.68 Details
Payment from Janssen Pharmaceuticals, Inc
Payment Record ID 366057252
04/19/2016 General (Non-Research) In-kind items and services Food and Beverage $12.68 Details
Payment from Janssen Pharmaceuticals, Inc
Payment Record ID 365364866
;